SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-05-000008
Filing Date
2005-03-14
Accepted
2005-03-14 16:16:12
Documents
2
Period of Report
2005-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR EARNINGS RELEASE 8K-4Q-2004 earnings8k4q04.htm 8-K 26670
2 DOR EARNINGS 4Q-04 PRESS RELEASE earnings4q04.htm EX-99.1 EARNINGS 23929
  Complete submission text file 0000812796-05-000008.txt   52599
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 05678626
SIC: 2834 Pharmaceutical Preparations